pulver til infusionsvæske clinical trials
3 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
A 12-Month, Randomized, Controlled, Open-Label, Dose Escalation Study Evaluating Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of an Anti-CD2 Monoclonal Antibody, TCD601(siplizumab) Compared to Anti-Thymocyte Globulin (rATG), as Induction Therapy in de novo Renal Transplant Recipients
This study looks at a new medicine called TCD601 (siplizumab) for people who have recently had a kidney transplant. It compares TCD601 to a standard treatment to see if it's safe and how well it helps prevent the body from rejecting the new kidney.
For: Renal TransplantationSweden · Spain · Austria - AuthorisedTherapeutic exploratory (Phase II)
Local Antibiotic Delivery for Community Acquired Pneumonia (LANDCAP 2)
This study is looking at new ways to treat pneumonia, a serious chest infection. We want to see if delivering antibiotics directly to the lungs, or using different antibiotics, helps people recover faster and spend less time in hospital. It's a key step in finding better treatments.
For: Community-acquired pneumoniaDenmark - AuthorisedHuman Pharmacology (Phase I)- Other
Intraperitoneal treatment with fosfomycin, metronidazole and recombinant human granulocyte-macrophage colony-stimulating factor in patients with multi-quadrant peritonitis undergoing abdominal surgery: A randomized placebo-controlled trial (TRIPLE)
This study is testing new treatments for a serious tummy infection called peritonitis. It aims to see if a mix of medicines given during surgery can help patients recover better and reduce problems like further infections or needing more surgery. Researchers want to find the best way to help people get well.
For: peritonitisDenmark